Vanishing bile duct syndrome in a HIV patient on HAART therapy
Jerome Gnanaraj1, Paul Fiedler, Michael Virata
1Department of Internal Medicine, Hospital of Saint Raphael, New Haven, Connecticut, United States. jgnanaraj@srhs.org
Insights
Vanishing bile duct syndrome, a disorder of bile duct destruction causing cholestasis, is often diagnosed histologically. This case highlights its development following highly active antiretroviral therapy.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- Vanishing bile duct syndrome (VBDS) is a cholestatic liver disease characterized by the progressive loss of intrahepatic bile ducts.
- It represents a final common pathway for diverse etiologies, with diagnosis primarily based on histological findings.
- Diagnostic criteria include the loss of interlobular bile ducts in over 50% of portal tracts in liver biopsy specimens.
Observation:
- This report details a specific case of vanishing bile duct syndrome.
- The syndrome's onset was observed subsequent to the initiation of highly active antiretroviral treatment (HAART).
Findings:
- The patient developed histological evidence of VBDS.
- The temporal association suggests a potential link between HAART and the development of bile duct injury.
Implications:
- This case underscores the importance of considering drug-induced liver injury, specifically HAART, as a potential cause of VBDS.
- Further research may be warranted to elucidate the mechanisms by which antiretroviral therapies can lead to bile duct destruction.
- Clinicians should maintain a high index of suspicion for VBDS in patients on HAART presenting with cholestatic liver injury.
Abstract:
Vanishing bile duct syndrome refers to a group of disorders characterised by progressive destruction of the intrahepatic bile ducts resulting in cholestasis. It is a final common pathway for many disorders. The diagnoses is mainly made by histological findings. To consider a diagnosis there should be loss of interlobular bile ducts in more than fifty per cent of small portal tracts provided that the specimen contains at least 10 portal tracts. Here the authors present a case of vanishing bile duct syndrome which developed after initiation of highly active antiretroviral treatment therapy.
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Pancreatitis II: Pathophysiology
Hepatitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Portal Hypertension
